These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6281371)

  • 1. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
    Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
    Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.
    Yoneyama T; Hagiwara A; Hara M; Shimojo H
    Infect Immun; 1982 Jul; 37(1):46-53. PubMed ID: 6179881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative biochemical studies of type 3 poliovirus.
    Minor PD
    J Virol; 1980 Apr; 34(1):73-84. PubMed ID: 6246264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
    Tagaya I; Nakao C; Hara M; Yamadera S
    Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease.
    Fiore L; Pierangeli A; Lombardi F; Santoro R; Crainic R; Venuti A; Perez-Bercoff R
    Intervirology; 1987; 27(4):196-204. PubMed ID: 2447031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of two different types of poliovirus isolated from a patient.
    Tsilimigras CW; Schoub BD
    J Infect; 1988 Sep; 17(2):159-61. PubMed ID: 2846704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the genome of poliovirus type 3 isolated from patients with poliomyelitis in Moldavia].
    Lipskaia GIu; Seĭbil' VB; Malyshkina LP; Gidirim VN; Drozdov SG
    Mol Gen Mikrobiol Virusol; 1985 Sep; (9):27-32. PubMed ID: 3025721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and biochemical characterization of poliovirus type 1 isolates.
    Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
    Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.
    Tatem JM; Weeks-Levy C; Mento SJ; DiMichele SJ; Georgiu A; Waterfield WF; Sheip B; Costalas C; Davies T; Ritchey MB
    J Med Virol; 1991 Oct; 35(2):101-9. PubMed ID: 1662701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
    Kew OM; Nottay BK; Hatch MH; Nakano JH; Obijeski JF
    J Gen Virol; 1981 Oct; 56(Pt 2):337-47. PubMed ID: 6273502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population.
    Magrath DI; Evans DM; Ferguson M; Schild GC; Minor PD; Horaud F; Crainic R; Stenvik M; Hovi T
    J Gen Virol; 1986 May; 67 ( Pt 5)():899-905. PubMed ID: 3009690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of monoclonal antibodies for the intratypic differentiation of strains of poliomyelitis type I virus].
    Lashkevich VA; Mustafina AN; Koroleva GA; Gracheva LA; Grishina KG
    Vopr Virusol; 1987; 32(2):183-8. PubMed ID: 2440185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
    Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.